Investigative Diligence
Our vision science, physician and industry experts have the experience needed to evaluate the potential of new assets for ocular therapy development, as well as a track record of success.
Assessment of:
-
Animal Models of Primary Pharmacology
-
Nonclinical Pharmacokinetics and Toxicology
-
CMC Developement
-
Regulatory Strategy
-
Clinical Development
-
Market Analysis